The global monoclonal antibody (mAb) therapeutics sector is undergoing a period of unprecedented transformation, driven by breakthroughs in biotechnology and a shifting geographic landscape. As healthcare systems worldwide prioritize precision medicine, the market—valued at US$252.6 billion in 2024—is poised to grow at a compound annual growth
The global sleep apnea devices market is undergoing a period of rapid technological evolution, catalyzed by a massive pool of undiagnosed patients and a fundamental shift toward home-based diagnostic and therapeutic solutions. According to the latest industry data, the Global Sleep Apnea Devices Market, valued at US$6.93 billion
The global pharmaceutical drying equipment market is entering a period of significant transformation, driven by an unprecedented surge in biopharmaceutical production and the expansion of high-tech manufacturing facilities. Valued at US$5.80 billion in 2024, the market is on a steady trajectory to reach an estimated US$8.18
The global biotechnology sector is witnessing a transformative shift as the oligonucleotide synthesis market is projected to reach a valuation of USD 24.70 billion by 2030. Rising from USD 10.50 billion in 2025, the industry is expanding at a robust Compound Annual Growth Rate (CAGR) of 18.6%
The global human microbiome market is entering a transformative era of clinical and commercial expansion. Valued at USD 1.40 billion in 2025, the industry is projected to surge to USD 7.09 billion by 2031, progressing at a remarkable Compound Annual Growth Rate (CAGR) of 31.0%. This trajectory
The global Artificial Intelligence (AI) in healthcare market is entering a period of unprecedented transformation. According to latest industry analysis, the market is projected to surge from USD 21.66 billion in 2025 to a staggering USD 110.61 billion by 2030. This trajectory represents a remarkable Compound Annual Growth
The healthcare landscape is undergoing a fundamental shift as data-driven decision-making moves from controlled clinical environments into the "real world." According to a new market analysis by MarketsandMarkets, the global Real-World Evidence (RWE) solutions market is projected to skyrocket from its 2024 valuation of USD 4.74 billion
The global gene editing market is poised for a period of robust expansion, with new projections estimating the sector will reach $7.59 billion by 2029. According to the latest industry analysis from MarketsandMarkets, the market—valued at $4.66 billion in 2024—is expected to grow at a Compound
The global radiotherapy market is entering a phase of significant expansion, driven by a surge in cancer cases and rapid technological innovation. According to a new report from MarketsandMarkets, the industry—valued at $7.21 billion in 2024—is projected to grow at a steady annual rate of 4.9%
The scientific landscape in Brazil is undergoing a profound shift as laboratories across the country transition from manual, paper-based record-keeping to sophisticated, automated digital ecosystems. At the heart of this evolution is the Laboratory Information Management System (LIMS). According to recent industry analysis by MarketsandMarkets, the global LIMS market is
The global Injectable Drug Delivery Market is witnessing strong and sustained growth, supported by rising demand for biologics, increasing prevalence of chronic diseases, and rapid advancements in self-administration technologies. According to the report “Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic, Usage Pattern, Administration, End Users & Region – Global
The global human microbiome market is witnessing rapid expansion, driven by rising interest in microbiome-based therapies, diagnostics, and precision health solutions. According to the report “Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics, Diagnostics), Disease (Infectious, Gastrointestinal), Route (Oral, Rectal), CDMO (Formulation, Strain Engineering), Type (BCT/FMT, Live Bacteria)
The global cell culture market is experiencing robust growth, driven by rapid advancements in biopharmaceutical manufacturing, cell and gene therapy development, and automation in life sciences research. According to the report “Cell Culture Market by Product (Consumables, Equipment), Application (mAbs, Vaccines, CGT), End User – Global Forecast to 2030,” the market
The global contrast media market is experiencing steady growth, driven by rising diagnostic imaging volumes, expanding healthcare infrastructure, and continuous innovation in imaging technologies. According to the report “Contrast Media Market by Type (Iodinated Contrast Media), Form (Liquid, Powder), Modality (X-ray, CT, MRI, Ultrasound), Route of Administration (Oral, Rectal), Indication
The global Europe pen needles market, valued at US$0.66 billion in 2025, stood at US$0.72 billion in 2026 and is projected to advance at a resilient CAGR of 8.9% from 2026 to 2031, culminating in a forecasted valuation of US$1.10 billion by the
The Europe Artificial Intelligence (AI) in Healthcare Market, valued at USD 4.20 billion in 2024, stood at USD 6.12 billion in 2025 and is projected to advance at a resilient CAGR of 39.0% from 2025 to 2030, culminating in a forecasted valuation of USD 31.72 billion
The US pen needles market, valued at US$0.85 billion in 2025, stood at US$0.93 billion in 2026 and is projected to advance at a resilient CAGR of 10.4% from 2026 to 2031, culminating in a forecasted valuation of US$1.53 billion by the end
The Europe remote patient monitoring (RPM) market is projected to reach USD 11.22 billion by 2030 from USD 6.87 billion in 2025, at a CAGR of 10.3% from 2025 to 2030. Market growth is driven by rising investments in home-based care models, strengthening cross-border digital health infrastructure,
The Europe Human Microbiome Market, valued at US$0.22 billion in 2024, stood at US$0.29 billion in 2025 and is projected to advance at a resilient CAGR of 28.6% from 2025 to 2031, culminating in a forecasted valuation of US$1.31 billion by the end
The Asia Pacific in vitro diagnostics market is valued at an estimated USD 29.27 billion in 2026 and is projected to reach USD 45.11 billion by 2031 at a CAGR of 9.0% during the forecast period. Market expansion is being driven by increased access to diagnostic services,
The North America Human Microbiome market, valued at US$0.43 billion in 2024, stood at US$0.78 billion in 2025 and is projected to advance at a resilient CAGR of 32.2% from 2025 to 2031, culminating in a forecasted valuation of US$4.15 billion by the
The Europe pharmaceutical drug delivery market is expected to grow from USD 519.62 billion in 2026 to USD 703.19 billion by 2031, with a CAGR of 6.2%. Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=148622116 The market growth is driven by rising use
The North America healthcare simulation market, valued at US$1.28 billion in 2024, stood at US$1.48 billion in 2025 and is projected to advance at a resilient CAGR of 15.1% from 2024 to 2030, culminating in a forecasted valuation of US$2.99 billion by the
The Europe Cleanroom Technologies market, valued at USD 2.45 billion in 2025, stood at USD 2.60 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2031, culminating in a forecasted valuation of USD 3.61 billion by the end